Skip to content

Good afternoon · 29 October, Thursday

16° Partly cloudy
USD 49.84 ▲0.10 EUR 55.48 ▼0.05 GBP 66.22 ▼0.20 CHF 60.00 ▼0.14
C CNBC · 3 h ago Follow Companies

Eli Lilly is about to report earnings. Here's what to expect

Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.

This story comes from CNBC's feed; the full article and all rights belong to the source.

0

Report / takedown request

Your report is sent to our team and reviewed.

0

Comments (0)

No comments yet. Be the first to comment.

Sign in to write a comment.

Related news